ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Combinational study with network pharmacology, molecular docking and preliminary experiments on exploring common mechanisms underlying the effects of weijing decoction on various pulmonary diseases

Li, Jia-Xin; Han, Zhong-Xiao; Cheng, Xin; Zhang, Feng-Lin; Zhang, Jing-Yi; Su, Zi-Jie; Li, Biao-Ping; Jiang, Zhi-Rui; Li, Run-Ze; Xie, Ying; Yan, Pei-Yu*; Tang, Ling*; Yang, Jia-Shun*广东省人民医院; 广州中医药大学; 南方医科大学; 中山大学; 5
Heliyon2023-5DOI: 10.1016/j.heliyon.2023.e15631
1被引31阅读
引用收藏
分享

摘要

Objective: 'Homotherapy for heteropathy' is a theory by which different diseases with similar pathogenesis can be treated with one Chinese formula. We aimed to explore the key components and core targets of Weijing decoction (WJD) in treating various lung diseases, namely, pneu-monia, chronic obstructive pulmonary disease (COPD), acute lung injury (ALI), pulmonary fibrosis, pulmonary tuberculosis and non-small cell lung cancer (NSCLC), via network pharma-cology, molecular docking and some experiments. Significance: This is the first study on the mechanism of WJD in treating various lung diseases by 'homotherapy for heteropathy'. This study is helpful for the transformation of TCM formula and development of new drugs.Methods: Active components and therapeutic targets of WJD were obtained via TCMSP and UniProt databases. Targets of the six pulmonary diseases were harvested from the GeneCards TTD, DisGeNet, UniProt and OMIM databases. Drug-disease intersection targets, corresponding Venn diagrams, herb-component-target networks and protein-protein interaction networks were established. Furthermore, GO biological function and KEGG enrichment analysis were completed. Moreover, the binding activity between main compounds and core targets was measured through molecular docking. Finally, the xenograft NSCLC mouse model was established. Immune responses were evaluated by flow cytometry and mRNA expression levels of critical targets were measured by real-time PCR.Results: JUN, CASP3 and PTGS2 were the most critical targets in six pulmonary diseases. The active compounds beta-sitosterol, tricin and stigmasterol stably bound to many active sites on target proteins. WJD had extensive pharmacological regulation, involving pathways related to cancer, inflammation, infection, hypoxia, immunity and so on.Conclusions: Effects of WJD against various lung diseases involve lots of compounds, targets and pathways. These findings will facilitate further research as well as clinical application of WJD.

学科与关键词

关键词
Weijing decoctionPulmonary diseaseNetwork pharmacologyMolecular dockingMechanismExperimental validation
相关
加载中…
  • Exploration of the Mechanism of Lianhua Qingwen in Treating Influenza Virus Pneumonia and New Coronavirus Pneumonia with the Concept of "Different Diseases with the Same Treatment" Based on Network Pharmacology
    Su, Huihui*; Wu, Guosong; Zhan, Lulu; Xu, Fei; Qian, Huiqin; Li, Yanling; Zhu, Ximei*Evidence-based Complementary and Alternative Medicine, 2022, 2022: 5536266.被引 7
  • Decoding the key compounds and mechanism of Shashen Maidong decoction in the treatment of lung cancer
    Cai, Jieqi; Chen, Yupeng; Wang, Kexin; Li, Yi; Wu, Jie; Yu, Hailang; Li, Qingping; Wu, Qi; Meng, Wei; Wang, Handuo; Lu, Aiping; Huang, Mianbo*; Wei, Genxia*; Guan, Daogang*BMC Complementary Medicine and Therapies, 2023, 23(1): 158.被引 2
  • Determining the mechanism of action of the Qishan formula against lung adenocarcinoma by integration of network pharmacology, molecular docking, and proteomics
    Geng, Xue; Chi, Wencheng; Lin, Xiaoyue; Niu, Zeji; Jiang, Qinghui; Sui, Yutong; Jiang, Jiakang*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2023, 102(13).
查看全部 →

发表信息

论文状态
公开发表
期刊
Heliyon
发表日期
2023-05
卷期
第 9 卷, 第 5 期
页码
e15631
DOI
10.1016/j.heliyon.2023.e15631
成果收录
SCIE
资助标注
Science and Technology Development Fund, Macau SAR [0011/2021/A]; 2021 Guangdong Provincial Science and Technology Innovation Strategy Special Fund ("Climbing Plan") [pdjh2021b010]

作者

  • L

    Li, Jia-Xin (第一作者)

  • H

    Han, Zhong-Xiao

    southern med univ

查看全部 13 位作者收起作者
  • C

    Cheng, Xin

    southern med univ

  • Z

    Zhang, Feng-Lin

    southern med univ

  • Z

    Zhang, Jing-Yi

    southern med univ

  • S

    Su, Zi-Jie

    southern med univ

  • L

    Li, Biao-Ping

    southern med univ

  • J

    Jiang, Zhi-Rui

    southern med univ

  • L

    Li, Run-Ze

    guangdong prov acad chinese med sci · guangdong prov hosp · guangzhou univ chinese med

  • X

    Xie, Ying

    5 · sun yat sen univ

  • Y

    Yan, Pei-Yu (通讯)

  • T

    Tang, Ling (通讯)

    southern med univ

  • Y

    Yang, Jia-Shun (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417